Compounds > lenalidomide
Page last updated: 2024-09-05

lenalidomide and clemastine

lenalidomide has been researched along with clemastine in 2 studies

Compound Research Comparison

Studies
(lenalidomide)		Trials
(lenalidomide)		Recent Studies (post-2010)
(lenalidomide)		Studies
(clemastine)		Trials
(clemastine)		Recent Studies (post-2010) (clemastine)
3,5327252,85034710566

Protein Interaction Comparison

ProteinTaxonomylenalidomide (IC50)clemastine (IC50)
Solute carrier family 22 member 1 Homo sapiens (human)4.9
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.099
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)3.086
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.02
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0084
Alpha-2A adrenergic receptorHomo sapiens (human)0.183
Cytochrome P450 2D6Homo sapiens (human)3
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.3951
D(2) dopamine receptorHomo sapiens (human)0.136
Alpha-2B adrenergic receptorHomo sapiens (human)0.311
Alpha-2C adrenergic receptorHomo sapiens (human)0.095
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.039
D(1A) dopamine receptorHomo sapiens (human)1.535
Sodium-dependent noradrenaline transporter Homo sapiens (human)3.086
Histamine H2 receptorHomo sapiens (human)0.37
Alpha-1D adrenergic receptorHomo sapiens (human)0.032
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.032
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.099
Cytochrome P450 2C19Homo sapiens (human)0.6
Histamine H1 receptorHomo sapiens (human)0.0004
D(3) dopamine receptorHomo sapiens (human)0.0073
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.036
5-hydroxytryptamine receptor 6Homo sapiens (human)0.077
5-hydroxytryptamine receptor 7Cavia porcellus (domestic guinea pig)4.9
Sodium-dependent dopamine transporter Homo sapiens (human)0.678
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.3951
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)0.3951
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.034

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ekins, S; Puhl, AC; Urbina, F1

Reviews

2 review(s) available for lenalidomide and clemastine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Recent advances in drug repurposing using machine learning.
    Current opinion in chemical biology, 2021, Volume: 65

    Topics: Alzheimer Disease; Antineoplastic Agents; Antiviral Agents; Clemastine; Computational Biology; COVID-19 Drug Treatment; Dipyridamole; Drug Repositioning; Humans; Hydroxychloroquine; Lenalidomide; Machine Learning; Neoplasms; Neuroprotective Agents; Piperazines; Piperidines; Protein Kinase Inhibitors

2021